The Maidstone and Tunbridge Wells NHS Trust has been recognised for its exceptional recruitment efforts in a significant study investigating treatments for wrist fractures. The DRAFT3 trial compares the effectiveness of traditional plaster casts with removable splints for patients aged 16 and over.
Traditionally, wrist fractures are managed with a plaster cast for four to six weeks. However, recent research suggests a removable splint may provide similar support and be more convenient for patients, potentially reducing the need for follow-up hospital visits. The study aims to assess patients' pain levels and their ability to carry out everyday activities.
During the recruitment period, over 540 patients were screened, with 109 agreeing to participate. Of these, 54 were assigned to receive a cast and 55 to receive a splint. Patients in both groups will be followed up for one year to monitor their progress.
The success in recruiting a large number of participants was attributed to the collaborative efforts of doctors and emergency practitioners in urgent care and the Virtual Fracture Clinic, who completed study training and provided support. The research was led at the Trust by Principal Investigator, Anna Tunnicliff; Consultant Orthopaedic Surgeon, Mr Ranjit Sehjal; and associate principal investigators, Dr Chiedozie Ikwu and Sarah de Coverley, Advanced Clinical Practitioner.
The DRAFT3 team also recognised 41 colleagues for their contribution to this vital research, acknowledging the Trust as one of the study’s leading recruiters. This research has the potential to improve patient experience while reducing healthcare costs and minimising the need for additional, time-consuming hospital appointments.
Research of this kind is vital in ensuring patients receive evidence-based care. For more information about taking part in research at MTW, email mtw-tr.researchgovernance@nhs.net.
